Cullinan Oncology
CGEM
CGEM
103 hedge funds and large institutions have $330M invested in Cullinan Oncology in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
9% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 34
17% less capital invested
Capital invested by funds: $396M → $330M (-$66.6M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
103
Holding in Top 10
3
Calls
$29K
Puts
$15K
Top Buyers
| 1 | +$3.87M | |
| 2 | +$1.95M | |
| 3 | +$1.42M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$767K |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$578K |
Top Sellers
| 1 | -$44.1M | |
| 2 | -$8.07M | |
| 3 | -$3.16M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.64M |
| 5 |
BlackRock
New York
|
-$2.56M |